AI Verdict
RANI has stronger fundamentals based on our AI analysis.
RANI vs RAL Fundamental Comparison
| Metric | RANI | RAL |
|---|---|---|
| Revenue | $1.6M | $2.1B |
| Net Income | $-29.7M | $-1.2B |
| Net Margin | -1,817.1% | -59.1% |
| ROE | -89.9% | -74.8% |
| ROA | -50.6% | -32.0% |
| Current Ratio | 4.21x | 0.84x |
| Debt/Equity | 0.00x | 0.70x |
| EPS | $-0.45 | $-10.84 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
RANI vs RAL: Frequently Asked Questions
Is RANI or RAL a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), RANI has stronger fundamentals. RANI is rated SELL (48% confidence) while RAL is rated STRONG SELL (82% confidence). This is not investment advice.
How does RANI compare to RAL fundamentally?
Rani Therapeutics Holdings, Inc. has ROE of -89.9% vs Ralliant Corp's -74.8%. Net margins are -1,817.1% vs -59.1% respectively.
Which stock pays higher dividends, RANI or RAL?
RANI has a dividend yield of N/A or no dividend while RAL has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in RANI or RAL for long term?
For long-term investing, consider that RANI has SELL rating with 48% confidence, while RAL has STRONG SELL rating with 82% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about RANI vs RAL?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For RANI vs RAL, the AI consensus favors RANI based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.